Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079181 · ClinicalTrials.gov registry record · NA
18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02079181: Clinical Trial NA study, sponsored by University of Southern California.
NCT02079181 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02079181, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This clinical trial studies the safety and drug distribution of the radioactive drug, 2'-deoxy-2'-\[18F\]fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (fluorine F 18 d-FMAU \[18F-FMAU\]), for imaging with positron emission tomography/computed tomography (PET/CT) in patients with advanced cancers. A PET scan is a procedure in which a small amount of radioactive glucose (sugar) is injected into a vein, and a scanner is used to make detailed, computerized pictures of areas inside the body where the glucose is taken up. Because cancer cells often take up more glucose than normal cells, the pictures can be used to find cancer cells in the body. PET/CT using the drug fluorine F 18 d-FMAU, may help find cancer and find out how far the disease has spread.
Interventions
- PROCEDURE positron emission tomography
- PROCEDURE computed tomography
- RADIATION fluorine F 18 d-FMAU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-01-31 |
| Est. Completion | 2023-08-22 |
| Phase | NA |
Why NCT02079181 stopped before completion
NCT02079181 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which positron emission tomography is the first listed.
NCT02079181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02079181 about?
NCT02079181 is a clinical study titled "18F-FMAU PET/CT in Imaging Patients With Advanced Cancers". This clinical trial studies the safety and drug distribution of the radioactive drug, 2'-deoxy-2'-\[18F\]fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (fluorine F 18 d-FMAU \[18F-FMAU\]), for imaging with positron emission tomography/computed tomography (PET/CT) in patients with advanced cancers. ...
What is the current status of trial NCT02079181?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2014-01-31. Estimated completion is 2023-08-22.
What interventions are being tested in trial NCT02079181?
The interventions under investigation include: positron emission tomography (PROCEDURE), computed tomography (PROCEDURE), fluorine F 18 d-FMAU (RADIATION).
Who is sponsoring clinical trial NCT02079181?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02079181's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI